account_balanceBalance Sheet (BS) Summary

Updated: 06/30/20262026 Q2

Total Assets

1.6B USD

YoY +45.5%

Shareholders' Equity

1.5B USD

YoY +55.4%

Equity Ratio

91.7%

YoY +5.8pt

Book Value Per Share

15.37USD

YoY +27.3%

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %

200150100500

2021

2022

2023

2024

2025

Balance Sheet Details

Unit: USD

Item

2018

2019

2020

2021

2022

2023

2024

2025

Cash

Cash and Equivalents

Short-term Investments

Net Receivables

Inventory

Other Current Assets

Total Current Assets

357.01M

491.26M

0

22.94M

871.21M

Goodwill

Intangible Assets

Property, Plant and Equipment

Property, Plant and Equipment Net

Long-term Investments

Other Assets

Other Non-current Assets

Net Tangible Assets

Non-current Assets Total

Total Assets

0

85.53M

776.96M

0

9.11M

1.74B

871.60M

1.74B

Accounts Payable

Short-term Debt

Short/Current Long-term Debt

Current Deferred Revenue

Other Current Liabilities

Total Current Liabilities

4.01M

13.76M

22.93M

24.20M

83.21M

Long-term Debt

Long-term Debt Total

Capital Lease Obligations

Other Non-current Liabilities

Net Debt

Non-current Liabilities Total

Total Liabilities

0

82.25M

68.50M

0

-274.76M

79.94M

163.15M

Common Stock

Common Stock Shares Outstanding

Additional Paid-in Capital

Retained Earnings

Accumulated Other Comprehensive Income

Other Stockholder Equity

Treasury Stock

Total Stockholder Equity

8,000

84.39M

2.64B

-1.07B

1.80M

0

1.58B

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan

Kymera Therapeutics, Inc.

account_balanceBalance Sheet (BS) Summary

Asset & Liability Mix

Equity Ratio Trend (5 Years)

Balance Sheet Details

Unlock Long-Term Balance Sheet Data